Pharmaceutical

FDA approves J&J’s Imaavy for generalised myasthenia gravis

J&J's Imaavy (nipocalimab-aahu) has received US Food and Drug Administration (FDA) approval for treating generalised myasthenia gravis.

May 2, 2025 - 06:00
FDA approves J&J’s Imaavy for generalised myasthenia gravis
J&J's Imaavy (nipocalimab-aahu) has received US Food and Drug Administration (FDA) approval for treating generalised myasthenia gravis.
Read the original article

Tags:

Previous Article

Novartis to strengthen renal disease portfolio with Regulus

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

GSK pill works in uncomplicated gonorrhea

GSK pill works in uncomplicated gonorrhea

Feb 27, 2024

STAT+: Sickle cell gene therapies could be cost-effective even if priced as high as $1.9 million

STAT+: Sickle cell gene therapies could be cost-effecti...

Apr 13, 2023

STAT+: FDA alters warning label for Carvykti CAR-T, although link to secondary cancers is unclear

STAT+: FDA alters warning label for Carvykti CAR-T, alt...

Dec 23, 2023